FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Source/Disclosures Published by: sources: Delany-Moretlwe S, et al. Abstract 5998. Presented at: International AIDS Society Conference on HIV Science; July
Read MoreThank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreThibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO
Read MoreJuly 21, 2023 3 minutes watch Source/Disclosures sources: Gupta R, et al. Barriers to early diet intervention. Presented at: Global
Read MoreThe herbal substance kratom (Mitragyna speciosa) has been the focus of much debate and regulatory wavering in the United States
Read MoreFor most of last year, St. Agnes Medical Center, based in Fresno, California, looked like a white knight poised to
Read MoreSource/Disclosures Published by: sources: Gao Y, et al. Abstract 1002. Presented at: International AIDS Society Conference on HIV Science; July
Read MoreSupporters hold up Save Medicaid signs during the Senate Democrats’ news conference at the Capitol with disability advocates to oppose
Read MoreSACRAMENTO, Calif. — California’s powerful health care industry just notched a historic win: The state is going to give it
Read More